The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer. (Q43152544)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 February 2010
edit
Language Label Description Also known as
English
The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.
scientific article published on 23 February 2010

    Statements

    The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer. (English)
    D Ross Camidge
    Henk M W Verheul
    Roshan Agarwal
    Debashis Sarker
    Stan B Kaye
    Ingrid M E Desar
    Johanna N H Timmer-Bonte
    S Gail Eckhardt
    Karl D Lewis
    Kathryn H Brown
    Mireille V Cantarini
    Clive Morris
    Sarah M A George
    Paul D Smith
    Carla M L van Herpen
    23 February 2010
    1613-1623

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit